BioMarin Pharmaceutical (BMRN) Stock

The Zacks Style Scores help investors quickly identify highly-rated stocks that match their investment preferences. Here are some reasons why you should make use of this tool.

Investors should closely monitor BioMarin Pharmaceutical (BMRN) stock due to recent changes in the options market.

No matter if you invest in value, growth, or momentum stocks, the Zacks Style Scores can help you identify strong stocks more easily. This is one of the key features of the Zacks Premium research service.

BioMarin (BMRN) shared its earnings report 30 days ago. What can we expect for the stock moving forward?

BioMarin Pharmaceutical, listed on NASDAQ as BMRN, has not been a good investment for quite some time. In the last decade, its shares have resulted in a total return of -28%.

Biomarin has a rare disease drug business that generates nearly $3 billion each year and is making a profit. Some believe the market does not fully recognize the company's value. However, it faces challenges with important drugs related to acondrophasia, hemophilia, and potential patent expirations, which could complicate its short-term future. In the long run, new management is aiming for $4 billion in revenue by 2027 and expects steady growth in the coming years.

SAN RAFAEL, Calif., Nov. 16, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has shared encouraging and consistent findings from several real-world studies on VOXZOGO® (vosoritide) for children with achondroplasia.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has announced that its management will speak at three investor conferences. The UBS Global Healthcare Conference is scheduled for November 12 at 11:00 am PST, followed by the Jefferies London Healthcare Conference on November 19 at 9:00 am GMT. Lastly, they will participate in the 7th Annual Evercore ISI HealthCONx Conference on December 4 at 7:00 am PST.

Are you looking for ways to choose powerful stocks that can outperform the market for your investment portfolio? The Zacks Style Scores can help you with that.